Article
Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity…
medRxiv · 2023 · Wang, X.; Su, S.; Zhu, Y.; Cheng, X.; Chen, C.; Chen, L.; Lei, A.; Zhang, L.; Xu, Y.; Li, W.; Zhang, Y.; Ye, D.; ZHANG, J.
Key facts
| Title | Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors |
|---|---|
| First author | Wang, X.; Su, S.; Zhu, Y.; Cheng, X.; Chen, C.; Chen, L.; Lei, A.; Zhang, L.; Xu, Y.; Li, W.; Zhang, Y.; Ye, D.; ZHANG, J. |
| Journal | medRxiv |
| Published | Apr 21, 2023 |
| DOI | 10.1101/2023.04.20.537647 |
| Devices mentioned | K810863 |
| Product codes mentioned | DBM, LXG, MVU, NSU, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1